Chong Y - Search Results

1

Plumbagin inhibits growth of gliomas in vivo via suppression of FOXM1 expression.

Niu M, Cai W, Liu H, Chong Y, Hu W, Gao S, Shi Q, Zhou X, Liu X, Yu R. Niu M, et al. Among authors: chong y. J Pharmacol Sci. 2015 Jul;128(3):131-6. doi: 10.1016/j.jphs.2015.06.005. Epub 2015 Jun 25. J Pharmacol Sci. 2015. PMID: 26154848 Free article.

2

Plumbagin induces growth inhibition of human glioma cells by downregulating the expression and activity of FOXM1.

Liu X, Cai W, Niu M, Chong Y, Liu H, Hu W, Wang D, Gao S, Shi Q, Hu J, Zhou X, Yu R. Liu X, et al. Among authors: chong y. J Neurooncol. 2015 Feb;121(3):469-77. doi: 10.1007/s11060-014-1664-2. Epub 2014 Dec 21. J Neurooncol. 2015. PMID: 25528634

3

Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells.

Niu M, Chong Y, Han Y, Liu X. Niu M, et al. Among authors: chong y. Cancer Biol Ther. 2015;16(7):1110-8. doi: 10.1080/15384047.2015.1047569. Epub 2015 May 21. Cancer Biol Ther. 2015. PMID: 25996664 Free PMC article.

4

Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer.

Liu X, Chong Y, Liu H, Han Y, Niu M. Liu X, et al. Among authors: chong y. J Ovarian Res. 2015 Jun 10;8:35. doi: 10.1186/s13048-015-0166-y. J Ovarian Res. 2015. PMID: 26055813 Free PMC article.

5

CRM1 inhibitor S109 suppresses cell proliferation and induces cell cycle arrest in renal cancer cells.

Liu X, Chong Y, Liu H, Han Y, Niu M. Liu X, et al. Among authors: chong y. Korean J Physiol Pharmacol. 2016 Mar;20(2):161-8. doi: 10.4196/kjpp.2016.20.2.161. Epub 2016 Feb 23. Korean J Physiol Pharmacol. 2016. PMID: 26937212 Free PMC article.

6

CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways.

Liu X, Chong Y, Tu Y, Liu N, Yue C, Qi Z, Liu H, Yao Y, Liu H, Gao S, Niu M, Yu R. Liu X, et al. Among authors: chong y. J Hematol Oncol. 2016 Oct 12;9(1):108. doi: 10.1186/s13045-016-0338-2. J Hematol Oncol. 2016. PMID: 27733172 Free PMC article.

7

SWAP-70 promotes glioblastoma cellular migration and invasion by regulating the expression of CD44s.

Shi L, Liu H, Wang Y, Chong Y, Wang J, Liu G, Zhang X, Chen X, Li H, Niu M, Liang J, Yu R, Liu X. Shi L, et al. Among authors: chong y. Cancer Cell Int. 2019 Nov 21;19:305. doi: 10.1186/s12935-019-1035-3. eCollection 2019. Cancer Cell Int. 2019. PMID: 31832018 Free PMC article.

8

Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway.

Liu X, Tu Y, Wang Y, Zhou D, Chong Y, Shi L, Liu G, Zhang X, Wu S, Li H, Gao S, Niu M, Yu R. Liu X, et al. Among authors: chong y. Cancer Cell Int. 2020 Mar 30;20:97. doi: 10.1186/s12935-020-01186-y. eCollection 2020. Cancer Cell Int. 2020. Retraction in: Cancer Cell Int. 2024 Sep 18;24(1):320. doi: 10.1186/s12935-024-03508-w PMID: 32256206 Free PMC article. Retracted.

9

Retraction Note: Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway.

Liu X, Tu Y, Wang Y, Zhou D, Chong Y, Shi L, Liu G, Zhang X, Wu S, Li H, Gao S, Niu M, Yu R. Liu X, et al. Among authors: chong y. Cancer Cell Int. 2024 Sep 18;24(1):320. doi: 10.1186/s12935-024-03508-w. Cancer Cell Int. 2024. PMID: 39294636 Free PMC article. No abstract available.

10

[Surgical treatment of trigeminal neuralgia by post-auricular suboccipital approach].

Liu XK, Shao T, Chong YJ. Liu XK, et al. Among authors: chong yj. Zhonghua Wai Ke Za Zhi. 1986 Jul;24(7):410-2, 446. Zhonghua Wai Ke Za Zhi. 1986. PMID: 3816453 Chinese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,476 results

Search Page

Filters